期刊文献+

国产阿立哌唑和利培酮治疗老年期精神分裂症对照研究

A clinical study on Aripiprazole versus Resperidone in treatment of senile schizophrenia
下载PDF
导出
摘要 目的:比较国产阿立哌唑(商品名:博思清)和利培酮对老年精神分裂症的治疗效果。方法:以阿立哌唑与利培酮对63例老年精神分裂症患者进行为期8周的对照治疗;采用阳性和阴性症状量表评定疗效,用副反应量表评定不良反应。结果:阿立哌唑组显效率71.8%,有效率91.8%;利培酮组显效率70.9%,有效率90.3%;不良反应均少而轻微,阿立哌唑主要不良反应为嗜睡,利培酮主要不良反应为锥体外系反应。结论:阿产哌唑和利培酮治疗老年期精神分裂症疗效相当,而且安全性高。 Objective: To compare the effects of Aripiprazole (Brisking) and Risperdal in senile schizophrenia. Methods: Aripiprazole and Risperdal to be used on 63 of senile schizophrenia for 8 weeks. PANSS and TESS were used to access the efficacy and side effects. Results: In Aripiprazole group, 71.8% showed significant efficacious and 91.8% efficacious, In Risperdal group , the ratio were 70.9% and 90.3% ; Both side effects in while , Both Aripiprazole group focused on drowsiness, In while in Risperdal group EPS. Conclusions: Both antipsychotic have equal efficacy and high safety in senile schizophrenics.
出处 《中国民康医学》 2007年第23期1027-1027,1034,共2页 Medical Journal of Chinese People’s Health
关键词 老年期精神分裂症 阿立哌唑 利培酮 Senile Schizophrenia Aripiprazole Risperdal
  • 相关文献

参考文献8

  • 1Lawler CP,Prioleau C,Lewis MM, et al . Interactions of the novel anti psychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes [J]. Neuro psychopharmacolgy, 1999,20 (6) :612-627.
  • 2Potkin SG,Saha AR,Kujawa MJ, et al. Aripiprazole, an Antipsy-chotic with a novel mechanism of action, and fispefidone vs placebo in patients with schizophrenia and schizoaffective disorder [J]. Arch Gen Psychiatry, 2003,60(7):681-690.
  • 3何燕玲,张明园.阳性和阴性综合征量表(PANSS)及其应用[J].临床精神医学杂志,1997,7(6):353-355. 被引量:481
  • 4张明园.精神科量表评定手册[M].长沙:湖南科学技术出版社,1998.17-27.
  • 5吴仁容,李乐华.新型抗精神病药:阿立哌唑[J].国外医学(精神病学分册),2004,31(3):177-179. 被引量:380
  • 6Hirose T, Uwahodo Y, yamada S, et al.Efficacy and fayorable side-effect profile of aripipr-axole determined in rat with apomorphine-induced stereotype, catalepsy, and ptosis induction [J]. Int J Neuropsychopharm, 2000,3 (Suppl):131-136.
  • 7Matsubayashi H, Amano T, Sasa M. Inhibition by aripipraxole of dopaminergic inputs to striatal neurons from substantia nigra [J]. Psychopharmacology (berl), 1999,146(2):139-143.
  • 8于欣,侯也之,舒良,王秀玲,李冰,刘卫红,林凯,杨顺才,宋丽华,廖安燕,谢家康,贾宏晓,张继志.利培酮治疗精神分裂症的开放性临床验证[J].中华精神科杂志,1997,30(2):79-82. 被引量:330

二级参考文献14

  • 1Kilkuchiet T,et al:J Pharmacol Exp Ther.1995;274(1):329—336.
  • 2Semba J,et al:Neuropharmacology,1995;34(7):785—791.
  • 3Fujikawa M,et al:Pharmacol Biochem Behav.1996;53(4):903—909.
  • 4Alison P,et al:Molecular Brain Research,1998;55:285—292.
  • 5Inoue A。et al:Brain Res Mol Brain Res.1998;55:285—292.
  • 6Shapine DA,et al:Neuropsychopharmacology,2003:1 46(5):214—216.
  • 7Bruce S:Drugs Research and Development,1999;2(1):47—48.
  • 8Stephen M,et al:Drugs oI the Future,2000;25(9):961—963.
  • 9Susman ED:Drugs oI the Future,1997;22(9):1029—1030.
  • 10McGavin JK,et al:CNS Drugs,2002;16(11):779—788.

共引文献1222

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部